All news

Resale offerings end at BioLife Solutions (BLFS), after prior registration of up to 927,165 shares.

Alpha Vantage · Stock Titan · · AI-summarised by FinFlash

BioLife Solutions, Inc. (BLFS) has terminated its resale stock offerings and deregistered all unsold securities that were part of a previous registration statement for up to 927,165 shares of common stock. This action follows a two-step merger completed on October 6, 2026, where BioLife Solutions became BioLife Solutions, LLC, a wholly owned subsidiary of Repligen Corporation. The termination aligns with undertakings to remove unsold securities after the offering's conclusion.

Read original source

BLFS company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.